首页 › 肝癌（肝细胞癌） › 华盛顿州 › Seattle
Seattle WA 肝癌（肝细胞癌）临床试验
10项针对 肝癌（肝细胞癌）的研究正在 Seattle及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
招募中1/2 期
- Research Facility, Seattle
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
招募中1/2 期
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center- Montlake, Seattle
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
招募中1/2 期
- Local Institution - 0083, Seattle
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
招募中1/2 期
- Fred Hutchinson Cancer Center, University of Washington, Seattle
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
招募中3 期
- Research Site, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- University of Washington School of Medicine, Seattle
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
招募中1/2 期
- Virginia Mason Medical Center, Seattle
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
招募中1 期
- Seattle Children's Hospital, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Seattle
其他城市的 肝癌（肝细胞癌）试验
- Houston, TX31 项研究
- New York City, NY24 项研究
- Dallas, TX19 项研究
- Los Angeles, CA19 项研究
- Boston, MA18 项研究
- Cleveland, OH18 项研究
- Chicago, IL16 项研究
- Philadelphia, PA16 项研究
- Pittsburgh, PA15 项研究
- San Francisco, CA14 项研究
- Orange, CA14 项研究
- Jacksonville, FL14 项研究
Seattle的其他研究
- 非小细胞肺癌53 项研究
- 癌症（所有类型）49 项研究
- 前列腺癌42 项研究
- 急性髓系白血病41 项研究
- 乳腺癌39 项研究
- 转移性癌症39 项研究
- 结直肠癌34 项研究
- 肺癌33 项研究
- 卵巢癌30 项研究
- 多发性骨髓瘤22 项研究
- 膀胱癌21 项研究
- 骨髓增生异常综合征21 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。